Atıf İçin Kopyala
IŞIK S., SILAN F., KILIÇ S., Hiz M. M., Ogretmen Z., ÖZDEMİR Ö.
EGYPTIAN RHEUMATOLOGIST, cilt.38, sa.4, ss.313-317, 2016 (ESCI)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
38
Sayı:
4
-
Basım Tarihi:
2016
-
Doi Numarası:
10.1016/j.ejr.2016.02.005
-
Dergi Adı:
EGYPTIAN RHEUMATOLOGIST
-
Derginin Tarandığı İndeksler:
Emerging Sources Citation Index (ESCI), Scopus
-
Sayfa Sayıları:
ss.313-317
-
Anahtar Kelimeler:
Psoriasis, Psoriatic arthritis, TNF-alpha-308G/A promoter polymorphism, TNF-alpha-238G/A promoter polymorphism, Tumor necrosis factor (TNF alpha), PASI, SUSCEPTIBILITY, ASSOCIATION, THERAPY, REGION
-
Çanakkale Onsekiz Mart Üniversitesi Adresli:
Evet
Özet
Introduction: Tumor necrosis factor-alpha (TNF-alpha) is an important proinflammatory cytokine playing a key role in the pathogenesis of psoriasis (Ps) and psoriatic arthritis (PsA). TNF alpha gene promoter region single nucleotide polymorphisms (SNPs) affect the clinical course, severity and the response to the treatment.